Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson is one of the top litigation firms in the country, handling local, national and international litigation. Our cases span from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America and Europe.
Our personal injury law firm has obtained hundreds of millions of dollars in verdicts and recoveries for clients and is recognized as a leader in plaintiffs’ personal injury and wrongful death cases, including catastrophic motor vehicle accidents; commercial and business torts; class actions and mass torts; and other areas of litigation including professional negligence, product liability and white collar criminal defense.
To schedule a consultation, do not hesitate to contact a personal injury attorney at our law office near Miami. We have experience in cases located throughout the nation and around the globe, and we have the experience to help you.
Coral Gables-based Colson Hicks Eidson has again been recognized as one of the top litigation firms in Florida. Similar to previous years, Colson Hicks Eidson has earned the highest honors – Band 1 – in the 2020 edition of Chambers USA, the world-leading legal guide that ranks and reviews law firms and lawyers.
Law.com: Two South Florida firms have united to file the first of what they say will be a string of putative mass tort lawsuits across the U.S. over allegations that a drug commonly prescribed for bladder issues could cause permanent retinal damage, vision impairment and blindness…
Elmiron is a prescription medication taken to treat interstitial cystitis. It is the only FDA-approved prescription medication to treat this disorder, which is also known as painful bladder syndrome. However,
Zantac and other ranitidine products have been under close scrutiny since last year after testing found high levels of a carcinogen known as N-nitrosodimethylamine (NDMA)inside the medications. Many pharmacies and
Allergan has faced intense scrutiny over the last year regarding their BIOCELL textured breast implants. Research indicates that these implants have increased the risk of a woman contracting breast implant-associated